首页 > 最新文献

Experimental Dermatology最新文献

英文 中文
Correction to ‘Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes’ 更正“粘多糖多磷酸盐在表皮中的药理作用涉及抑制角化细胞中两角调节蛋白介导的信号”。
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2025-01-12 DOI: 10.1111/exd.70016

R. Hirase, T. Fujita, T. Miyai, H. Kawasaki, and H. Koseki, “Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes,” Experimental Dermatology 33, no. 10 (2024): e70000.

In the article, there are several instances where the term ‘polyphosphates’ has been used incorrectly. The correct term is ‘polysulfate’. Therefore, all occurrences of ‘polyphosphates’ should be corrected to ‘polysulfate’.

The online version of the article has been corrected.

We apologise for this error.

{"title":"Correction to ‘Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes’","authors":"","doi":"10.1111/exd.70016","DOIUrl":"10.1111/exd.70016","url":null,"abstract":"<p>R. Hirase, T. Fujita, T. Miyai, H. Kawasaki, and H. Koseki, “Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes,” <i>Experimental Dermatology</i> 33, no. 10 (2024): e70000.</p><p>In the article, there are several instances where the term ‘polyphosphates’ has been used incorrectly. The correct term is ‘polysulfate’. Therefore, all occurrences of ‘polyphosphates’ should be corrected to ‘polysulfate’.</p><p>The online version of the article has been corrected.</p><p>We apologise for this error.</p>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"34 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/exd.70016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Genetic Biomarkers in Merkel Cell Carcinoma: Prognostic Implications and Predictive Utility for Response to Anti-PD-(L)1 Immune Checkpoint Inhibitors 默克尔细胞癌的非遗传生物标志物:对抗pd -(L)1免疫检查点抑制剂反应的预后意义和预测效用
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2025-01-10 DOI: 10.1111/exd.70030
David L. Drum, Anika G. Jallorina, Leo S. Wan, Victor T. Chang, Mary F. Lee-Wong

Merkel cell carcinoma (MCC) is a skin cancer that arises due to either Merkel cell polyomavirus infection (MCPyV) or ultraviolet (UV) radiation exposure, presenting primarily in the head and neck region of fair-skinned males. The recent success of PD-(L)1 immune checkpoint inhibitors (ICIs) in locally advanced/metastatic MCC, with an objective response rate (ORR) around 50% and improved survival, as a first-line treatment has moved ICIs to the forefront of therapy for MCC and generated interest in identifying biomarkers to predict clinical response. The MCC tumour microenvironment (TME) contains various components of the adaptive and innate immune system. These components can contribute to tumour immune escape through immunosuppression by preventing entrance of other immune cells or by aiding in the cytotoxic clearance of tumour cells. We aim to combine information from studies of baseline and on-treatment monitoring of the TME to help predict the success of ICIs in MCC. This review enhances the understanding of how CD8 T cells, γδ T cells and macrophages may impact predictions of response rates to ICIs in MCC patients. These immune cells are non-genetic biomarkers that can also be used to determine prognosis in MCC treatment.

梅克尔细胞癌(MCC)是一种由梅克尔细胞多瘤病毒感染(MCPyV)或紫外线(UV)辐射引起的皮肤癌,主要出现在皮肤白皙的男性头颈部。最近PD-(L)1免疫检查点抑制剂(ICIs)在局部晚期/转移性MCC中的成功,其客观缓解率(ORR)约为50%,并提高了生存率,作为一线治疗方法,将ICIs推向了MCC治疗的前沿,并引起了识别生物标志物以预测临床反应的兴趣。MCC肿瘤微环境(TME)包含适应性和先天免疫系统的各种组成部分。这些成分可以通过阻止其他免疫细胞的进入或帮助肿瘤细胞的细胞毒性清除来抑制肿瘤免疫逃逸。我们的目标是结合基线和治疗中监测TME的研究信息,以帮助预测ICIs在MCC中的成功。这篇综述加强了对CD8 T细胞、γδ T细胞和巨噬细胞如何影响MCC患者对ICIs反应率的预测的理解。这些免疫细胞是非遗传生物标志物,也可用于确定MCC治疗的预后。
{"title":"Non-Genetic Biomarkers in Merkel Cell Carcinoma: Prognostic Implications and Predictive Utility for Response to Anti-PD-(L)1 Immune Checkpoint Inhibitors","authors":"David L. Drum,&nbsp;Anika G. Jallorina,&nbsp;Leo S. Wan,&nbsp;Victor T. Chang,&nbsp;Mary F. Lee-Wong","doi":"10.1111/exd.70030","DOIUrl":"10.1111/exd.70030","url":null,"abstract":"<p>Merkel cell carcinoma (MCC) is a skin cancer that arises due to either Merkel cell polyomavirus infection (MCPyV) or ultraviolet (UV) radiation exposure, presenting primarily in the head and neck region of fair-skinned males. The recent success of PD-(L)1 immune checkpoint inhibitors (ICIs) in locally advanced/metastatic MCC, with an objective response rate (ORR) around 50% and improved survival, as a first-line treatment has moved ICIs to the forefront of therapy for MCC and generated interest in identifying biomarkers to predict clinical response. The MCC tumour microenvironment (TME) contains various components of the adaptive and innate immune system. These components can contribute to tumour immune escape through immunosuppression by preventing entrance of other immune cells or by aiding in the cytotoxic clearance of tumour cells. We aim to combine information from studies of baseline and on-treatment monitoring of the TME to help predict the success of ICIs in MCC. This review enhances the understanding of how CD8 T cells, γδ T cells and macrophages may impact predictions of response rates to ICIs in MCC patients. These immune cells are non-genetic biomarkers that can also be used to determine prognosis in MCC treatment.</p>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"34 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/exd.70030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142947101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microplastics and Skin Aging: Disruption of Barrier Function and Induction of Fibroblast Senescence
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-29 DOI: 10.1111/exd.70027
Yujie Ouyang, Songjiang Wu, Yuanyuan Zhao, Yibo Hu, Ling Jiang, Chuhan Fu, Li Lei, Yushan Zhang, Xiaolei Duan, Jinhua Huang, Jing Chen, Qinghai Zeng

Microplastics (MPs) have emerged as a major concern among contemporary pollutants, but there is still limited knowledge regarding their impact on skin function. To address this issue, we conducted a transcriptome analysis on skin tissue that had been exposed to polystyrene (PS), which is one of the most prevalent type of MPs that can be absorbed through the skin. The results of our study, obtained through functional enrichment analysis and the experiment of treating HaCaT with PS, revealed that PS may have an effect on skin barrier function, specifically the permeability barrier through inhibiting keratinocyte differentiation. Additionally, PS also induced dysfunction in the extracellular matrix (ECM). Mechanistically, we observed that PS induced fibroblasts senescence and increased the secretion of senescence-related characteristics. Furthermore, the expression of core genes related to the ECM, such as COL1A1, COL1A2 and SPP1, was found to be down-regulated in PS-treated fibroblasts. Moreover, an in vitro experiment provided evidence of the involvement of PPARγ in PS-induced fibroblast senescence. In conclusion, our study has identified PS as a causal factor for skin barrier dysfunction. Additionally, PS induces fibroblast senescence, leading to ECM dysfunction and contributing to skin aging. These findings further strengthen the understanding and management of the effects of MPs on skin health.

{"title":"Microplastics and Skin Aging: Disruption of Barrier Function and Induction of Fibroblast Senescence","authors":"Yujie Ouyang,&nbsp;Songjiang Wu,&nbsp;Yuanyuan Zhao,&nbsp;Yibo Hu,&nbsp;Ling Jiang,&nbsp;Chuhan Fu,&nbsp;Li Lei,&nbsp;Yushan Zhang,&nbsp;Xiaolei Duan,&nbsp;Jinhua Huang,&nbsp;Jing Chen,&nbsp;Qinghai Zeng","doi":"10.1111/exd.70027","DOIUrl":"https://doi.org/10.1111/exd.70027","url":null,"abstract":"<div>\u0000 \u0000 <p>Microplastics (MPs) have emerged as a major concern among contemporary pollutants, but there is still limited knowledge regarding their impact on skin function. To address this issue, we conducted a transcriptome analysis on skin tissue that had been exposed to polystyrene (PS), which is one of the most prevalent type of MPs that can be absorbed through the skin. The results of our study, obtained through functional enrichment analysis and the experiment of treating HaCaT with PS, revealed that PS may have an effect on skin barrier function, specifically the permeability barrier through inhibiting keratinocyte differentiation. Additionally, PS also induced dysfunction in the extracellular matrix (ECM). Mechanistically, we observed that PS induced fibroblasts senescence and increased the secretion of senescence-related characteristics. Furthermore, the expression of core genes related to the ECM, such as <i>COL1A1</i>, <i>COL1A2</i> and <i>SPP1</i>, was found to be down-regulated in PS-treated fibroblasts. Moreover, an in vitro experiment provided evidence of the involvement of PPARγ in PS-induced fibroblast senescence. In conclusion, our study has identified PS as a causal factor for skin barrier dysfunction. Additionally, PS induces fibroblast senescence, leading to ECM dysfunction and contributing to skin aging. These findings further strengthen the understanding and management of the effects of MPs on skin health.</p>\u0000 </div>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"34 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Potential Contribution of S100A11 to Skin Fibrosis and Pulmonary Involvement in Systemic Sclerosis
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-29 DOI: 10.1111/exd.70026
Takuya Takahashi, Takehiro Takahashi, Yuichiro Segawa, Tetsuya Ikawa, Hitoshi Terui, Toshiya Takahashi, Hayakazu Sumida, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano

Systemic sclerosis (SSc) is characterised by immune dysregulation, vasculopathy and fibrosis, driven by genetic and environmental factors. S100 proteins, which constitute a unique class of calcium-binding proteins, have been shown to be critically implicated in various inflammatory and fibrotic conditions. In this study, we investigated the possible involvement of S100A11 in SSc by examining its cutaneous expression and systemic serum levels, correlating them with key clinical parameters. First, we performed immunohistochemical (IHC) staining to examine S100A11 localisation in skin specimens from SSc patients and controls, and found that S100A11 was robustly expressed in SSc dermal fibroblasts. Analysis on the publicly available single-cell RNA-sequencing (scRNA-seq) data of SSc skin samples further confirmed that S100A11 was highly expressed in SSc dermal fibroblasts along with several key genes associated with cellular senescence. Finally, we evaluated serum levels of S100A11 in SSc patients and HCs using enzyme-linked immunosorbent assay (ELISA), and found that serum S100A11 levels were significantly elevated in diffuse cutaneous SSc (dcSSc) patients compared to controls. S100A11 serum levels in SSc patients were significantly correlated with modified Rodnan total skin thickness score and key parameters of SSc-related interstitial lung disease. Our data collectively suggested a potential pathophysiological role of S100A11 in the cutaneous and lung fibrosis associated with SSc, warranting further investigation into its functional roles in this disease.

{"title":"A Potential Contribution of S100A11 to Skin Fibrosis and Pulmonary Involvement in Systemic Sclerosis","authors":"Takuya Takahashi,&nbsp;Takehiro Takahashi,&nbsp;Yuichiro Segawa,&nbsp;Tetsuya Ikawa,&nbsp;Hitoshi Terui,&nbsp;Toshiya Takahashi,&nbsp;Hayakazu Sumida,&nbsp;Ayumi Yoshizaki,&nbsp;Shinichi Sato,&nbsp;Yoshihide Asano","doi":"10.1111/exd.70026","DOIUrl":"https://doi.org/10.1111/exd.70026","url":null,"abstract":"<div>\u0000 \u0000 <p>Systemic sclerosis (SSc) is characterised by immune dysregulation, vasculopathy and fibrosis, driven by genetic and environmental factors. S100 proteins, which constitute a unique class of calcium-binding proteins, have been shown to be critically implicated in various inflammatory and fibrotic conditions. In this study, we investigated the possible involvement of S100A11 in SSc by examining its cutaneous expression and systemic serum levels, correlating them with key clinical parameters. First, we performed immunohistochemical (IHC) staining to examine S100A11 localisation in skin specimens from SSc patients and controls, and found that S100A11 was robustly expressed in SSc dermal fibroblasts. Analysis on the publicly available single-cell RNA-sequencing (scRNA-seq) data of SSc skin samples further confirmed that S100A11 was highly expressed in SSc dermal fibroblasts along with several key genes associated with cellular senescence. Finally, we evaluated serum levels of S100A11 in SSc patients and HCs using enzyme-linked immunosorbent assay (ELISA), and found that serum S100A11 levels were significantly elevated in diffuse cutaneous SSc (dcSSc) patients compared to controls. S100A11 serum levels in SSc patients were significantly correlated with modified Rodnan total skin thickness score and key parameters of SSc-related interstitial lung disease. Our data collectively suggested a potential pathophysiological role of S100A11 in the cutaneous and lung fibrosis associated with SSc, warranting further investigation into its functional roles in this disease.</p>\u0000 </div>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"34 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone 在恶唑酮诱导的慢性皮炎小鼠模型中标准特应性皮炎治疗的特征和分析。
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-23 DOI: 10.1111/exd.70024
Elena Calama, Ana I. Blanco, Juan L. Trincado, Arsenio Nueda, Félix Gil, Gloria Aniorte, Nuria Godessart, Amadeu Gavaldà

Atopic dermatitis (AD) is a common inflammatory skin disorder characterised by hypersensitivity to allergens, eczematous lesions and pruritus. The aim of this study was to comprehensively characterise a murine model of dermatitis and assess the similarity with the human disease, as well as to profile clinically relevant AD therapies. Four repeated topical administrations of oxazolone in the auricular skin of sensitised mice induced morphological features compatible with AD, including redness and swelling, as well as histological changes typical of spongiotic (eczematous) dermatitis and increased plasmatic IgE. Additionally, key driver Type 2 cytokines involved in the pathophysiology of the disease, IL-4, IL-13 and IL − 31, were upregulated in the skin, along with cytokines related to Type 1, 17 and 22 responses, which have been reported to be relevant in the chronic stages of the disease. RNA-seq studies in OXA model mice samples validate expression changes obtained by q-PCR and suggest a greater significant similarity with the transcriptomic signature of human AD with respect to psoriasis studies. Oral (cyclosporine, prednisolone and baricitinib) and topical treatments (betamethasone, tacrolimus and crisaborole) were effective inhibiting the induced pathology, as well as modulating the cytokine gene signature of AD. In conclusion, our 4 oxazolone challenges model recapitulates many of the key features of the disease and is responsive to AD standard of care therapies in humans.

特应性皮炎(AD)是一种常见的炎症性皮肤病,其特征是对过敏原、湿疹病变和瘙痒过敏。本研究的目的是全面表征小鼠皮炎模型,评估其与人类疾病的相似性,以及临床相关的AD治疗方法。四次在致敏小鼠耳部皮肤上重复使用恶唑酮,可诱导与AD相一致的形态学特征,包括红肿,以及典型的海棉性(湿疹性)皮炎的组织学变化和血浆IgE升高。此外,参与该疾病病理生理的关键驱动型2细胞因子IL-4、IL-13和IL- 31在皮肤中上调,以及与1型、17型和22型反应相关的细胞因子,据报道这些细胞因子与该疾病的慢性阶段相关。OXA模型小鼠样本的RNA-seq研究验证了q-PCR获得的表达变化,并表明在牛皮癣研究中与人类AD的转录组特征有更大的相似性。口服(环孢素、强的松龙和巴西替尼)和外用(倍他米松、他克莫司和crisaborole)治疗可有效抑制AD诱导的病理,并调节AD的细胞因子基因特征。总之,我们的4恶唑酮挑战模型概括了该疾病的许多关键特征,并且对人类AD标准护理疗法有反应。
{"title":"Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone","authors":"Elena Calama,&nbsp;Ana I. Blanco,&nbsp;Juan L. Trincado,&nbsp;Arsenio Nueda,&nbsp;Félix Gil,&nbsp;Gloria Aniorte,&nbsp;Nuria Godessart,&nbsp;Amadeu Gavaldà","doi":"10.1111/exd.70024","DOIUrl":"10.1111/exd.70024","url":null,"abstract":"<div>\u0000 \u0000 <p>Atopic dermatitis (AD) is a common inflammatory skin disorder characterised by hypersensitivity to allergens, eczematous lesions and pruritus. The aim of this study was to comprehensively characterise a murine model of dermatitis and assess the similarity with the human disease, as well as to profile clinically relevant AD therapies. Four repeated topical administrations of oxazolone in the auricular skin of sensitised mice induced morphological features compatible with AD, including redness and swelling, as well as histological changes typical of spongiotic (eczematous) dermatitis and increased plasmatic IgE. Additionally, key driver Type 2 cytokines involved in the pathophysiology of the disease, IL-4, IL-13 and IL − 31, were upregulated in the skin, along with cytokines related to Type 1, 17 and 22 responses, which have been reported to be relevant in the chronic stages of the disease. RNA-seq studies in OXA model mice samples validate expression changes obtained by q-PCR and suggest a greater significant similarity with the transcriptomic signature of human AD with respect to psoriasis studies. Oral (cyclosporine, prednisolone and baricitinib) and topical treatments (betamethasone, tacrolimus and crisaborole) were effective inhibiting the induced pathology, as well as modulating the cytokine gene signature of AD. In conclusion, our 4 oxazolone challenges model recapitulates many of the key features of the disease and is responsive to AD standard of care therapies in humans.</p>\u0000 </div>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"33 12","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid of Deep Feature Extraction and Machine Learning Ensembles for Imbalanced Skin Cancer Datasets 不平衡皮肤癌数据集的深度特征提取与机器学习组合。
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-23 DOI: 10.1111/exd.70020
Neetu Verma,  Ranvijay, Dharmendra Kumar Yadav

Skin cancer remains one of the most common and deadly forms of cancer, necessitating accurate and early diagnosis to improve patient outcomes. In order to improve classification performance on unbalanced datasets, this study proposes a distinctive approach for classifying skin cancer that utilises both machine learning (ML) and deep learning (DL) methods. We extract features from three different DL models (DenseNet201, Xception, Mobilenet) and concatenate them to create an extensive feature set. Afterwards, several ML algorithms are given these features to be classified. We utilise ensemble techniques to aggregate the predictions from several classifiers, significantly improving the classification's resilience and accuracy. To address the problem of data imbalance, we employ class weight updates and data augmentation strategies to ensure that the model is thoroughly trained across all classes. Our method shows significant improvements over recent existing approaches in terms of classification accuracy and generalisation. The proposed model successfully received 98.7%, 94.4% accuracy, 99%, 95%, precision, 99%, 96% recall, 99%, and 96% f1-score for the HAM10000 and ISIC datasets, respectively. This study offers dermatologists and other medical practitioners' valuable insights into the classification of skin cancer.

皮肤癌仍然是最常见和最致命的癌症之一,需要准确和早期的诊断来改善患者的预后。为了提高在不平衡数据集上的分类性能,本研究提出了一种独特的方法来分类皮肤癌,该方法利用机器学习(ML)和深度学习(DL)方法。我们从三个不同的深度学习模型(DenseNet201, Xception, Mobilenet)中提取特征,并将它们连接起来创建一个广泛的特征集。然后,给出几种ML算法对这些特征进行分类。我们利用集成技术来聚合来自多个分类器的预测,显著提高了分类的弹性和准确性。为了解决数据不平衡的问题,我们采用了类权重更新和数据增强策略,以确保模型在所有类中都得到了彻底的训练。我们的方法在分类精度和泛化方面比最近现有的方法有了显著的改进。该模型在HAM10000和ISIC数据集上分别获得98.7%、94.4%的准确率、99%、95%、精密度、99%、96%的召回率、99%和96%的f1-score。这项研究为皮肤科医生和其他医疗从业者对皮肤癌的分类提供了宝贵的见解。
{"title":"Hybrid of Deep Feature Extraction and Machine Learning Ensembles for Imbalanced Skin Cancer Datasets","authors":"Neetu Verma,&nbsp; Ranvijay,&nbsp;Dharmendra Kumar Yadav","doi":"10.1111/exd.70020","DOIUrl":"10.1111/exd.70020","url":null,"abstract":"<div>\u0000 \u0000 <p>Skin cancer remains one of the most common and deadly forms of cancer, necessitating accurate and early diagnosis to improve patient outcomes. In order to improve classification performance on unbalanced datasets, this study proposes a distinctive approach for classifying skin cancer that utilises both machine learning (ML) and deep learning (DL) methods. We extract features from three different DL models (DenseNet201, Xception, Mobilenet) and concatenate them to create an extensive feature set. Afterwards, several ML algorithms are given these features to be classified. We utilise ensemble techniques to aggregate the predictions from several classifiers, significantly improving the classification's resilience and accuracy. To address the problem of data imbalance, we employ class weight updates and data augmentation strategies to ensure that the model is thoroughly trained across all classes. Our method shows significant improvements over recent existing approaches in terms of classification accuracy and generalisation. The proposed model successfully received 98.7%, 94.4% accuracy, 99%, 95%, precision, 99%, 96% recall, 99%, and 96% f1-score for the HAM10000 and ISIC datasets, respectively. This study offers dermatologists and other medical practitioners' valuable insights into the classification of skin cancer.</p>\u0000 </div>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"33 12","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Characteristics of Sweet Syndrome: A Systematic Review 甜证的分子特征:系统综述。
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-20 DOI: 10.1111/exd.70022
Laura Calabrese, Maurizio Romagnuolo, Martina D'Onghia, Pietro Rubegni, Angelo V. Marzano, Chiara Moltrasio

Sweet syndrome (SS), originally described as acute febrile neutrophilic dermatosis, is a rare inflammatory skin condition, considered the prototype of neutrophilic dermatoses. It is characterised by the sudden onset of well-defined tender papules, plaques and nodules often accompanied by fever, neutrophilia and elevated markers of inflammation. Several variants have been described both clinically and histopathologically. Classifications include idiopathic, malignancy-associated, and drug-induced SS. The exact pathogenesis of SS is still unclear; however, recent findings have shed light on the role of dermal infiltrating neutrophils—in the context of innate immunity, and signalling pathways related to adaptive immunity. To critically analyse the current molecular landscape of SS and discuss the recent evidence supporting novel potential immune mediators and biological signalling pathways involved in SS pathogenesis. The methodology followed PRISMA guidelines and included two bibliographical databases, searching articles published until 17 December 2023. Titles, abstracts and full text were reviewed independently by two assessors, while other two investigators resolved any opinion differences. Of 3303 records identified through database search, 22 articles met the eligibility criteria for inclusion. We considered experimental studies that performed molecular analysis, in terms of cytokines quantification, gene expression and/or immunofluorescence/immunohistochemistry. As for the latter, only studies aimed at characterising the nature of the inflammatory infiltrate and potential mechanisms leading to distinct forms of cutaneous inflammatory cell influx were included. Overall, we described research on 202 SS patients (177 skin biopsies and 25 blood specimens) revealing the predominant role of neutrophil activation and abnormal proliferation as unifying mechanisms in different SS subtypes. Interestingly, we found that hyperactivation of the IL-1 pathway might occur only in a subset of SS patients and adaptive immunity could also play a role in the pathogenic scenario of SS, with a potential significant role of IL-17 axis. This systematic review provides a wealth of evidence on the molecular landscape of SS, although further research is needed to a deeper understanding of the patho-mechanisms of this rare disease and hopefully lead to targeted therapeutic approaches.

Sweet综合征(SS),最初被描述为急性发热性中性粒细胞皮肤病,是一种罕见的炎症性皮肤病,被认为是中性粒细胞皮肤病的原型。其特点是突然出现界限明确的丘疹、斑块和结节,常伴有发热、中性粒细胞增多和炎症标志物升高。临床和组织病理学上已经描述了几种变异。分类包括特发性、恶性相关和药物诱导的SS。SS的确切发病机制尚不清楚;然而,最近的研究结果揭示了皮肤浸润中性粒细胞在先天免疫和与适应性免疫相关的信号通路中的作用。批判性地分析当前SS的分子格局,并讨论支持新的潜在免疫介质和参与SS发病机制的生物信号通路的最新证据。该方法遵循PRISMA指南,包括两个书目数据库,检索到2023年12月17日之前发表的文章。标题、摘要和全文由两名审查员独立审阅,而其他两名研究者解决意见分歧。在通过数据库检索确定的3303条记录中,有22篇文章符合纳入的资格标准。我们考虑了在细胞因子定量、基因表达和/或免疫荧光/免疫组织化学方面进行分子分析的实验研究。至于后者,仅包括旨在表征炎症浸润的性质和导致不同形式的皮肤炎症细胞内流的潜在机制的研究。总的来说,我们描述了202例SS患者(177例皮肤活检和25例血液标本)的研究,揭示了中性粒细胞活化和异常增殖在不同SS亚型中的统一机制。有趣的是,我们发现IL-1通路的过度激活可能只发生在一小部分SS患者中,适应性免疫也可能在SS的发病过程中发挥作用,IL-17轴可能发挥重要作用。尽管需要进一步的研究来更深入地了解这种罕见疾病的病理机制,并有希望找到针对性的治疗方法,但该系统综述为SS的分子景观提供了丰富的证据。
{"title":"Molecular Characteristics of Sweet Syndrome: A Systematic Review","authors":"Laura Calabrese,&nbsp;Maurizio Romagnuolo,&nbsp;Martina D'Onghia,&nbsp;Pietro Rubegni,&nbsp;Angelo V. Marzano,&nbsp;Chiara Moltrasio","doi":"10.1111/exd.70022","DOIUrl":"10.1111/exd.70022","url":null,"abstract":"<p>Sweet syndrome (SS), originally described as acute febrile neutrophilic dermatosis, is a rare inflammatory skin condition, considered the prototype of neutrophilic dermatoses. It is characterised by the sudden onset of well-defined tender papules, plaques and nodules often accompanied by fever, neutrophilia and elevated markers of inflammation. Several variants have been described both clinically and histopathologically. Classifications include idiopathic, malignancy-associated, and drug-induced SS. The exact pathogenesis of SS is still unclear; however, recent findings have shed light on the role of dermal infiltrating neutrophils—in the context of innate immunity, and signalling pathways related to adaptive immunity. To critically analyse the current molecular landscape of SS and discuss the recent evidence supporting novel potential immune mediators and biological signalling pathways involved in SS pathogenesis. The methodology followed PRISMA guidelines and included two bibliographical databases, searching articles published until 17 December 2023. Titles, abstracts and full text were reviewed independently by two assessors, while other two investigators resolved any opinion differences. Of 3303 records identified through database search, 22 articles met the eligibility criteria for inclusion. We considered experimental studies that performed molecular analysis, in terms of cytokines quantification, gene expression and/or immunofluorescence/immunohistochemistry. As for the latter, only studies aimed at characterising the nature of the inflammatory infiltrate and potential mechanisms leading to distinct forms of cutaneous inflammatory cell influx were included. Overall, we described research on 202 SS patients (177 skin biopsies and 25 blood specimens) revealing the predominant role of neutrophil activation and abnormal proliferation as unifying mechanisms in different SS subtypes. Interestingly, we found that hyperactivation of the IL-1 pathway might occur only in a subset of SS patients and adaptive immunity could also play a role in the pathogenic scenario of SS, with a potential significant role of IL-17 axis. This systematic review provides a wealth of evidence on the molecular landscape of SS, although further research is needed to a deeper understanding of the patho-mechanisms of this rare disease and hopefully lead to targeted therapeutic approaches.</p>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"33 12","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/exd.70022","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CD4+ T Cells Occupy Perivascular and Perifollicular Niches in Healthy Human Skin 健康人体皮肤中占据血管周围和毛囊周围壁龛的 CD4+ T 细胞
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-13 DOI: 10.1111/exd.70023
Courtney E. Macon, Annie Yang, Dhara Patel, Jeffrey P. North, Michael D. Rosenblum, Jarish N. Cohen

Regulatory T cells (Tregs) are specialised T lymphocytes that sit at the nexus of immune regulation and tissue repair. While it is appreciated that a substantial number of Tregs are present in healthy human skin, less is known about their microanatomic spatial localisation. Knowledge about the specialised niches that Tregs occupy may aid in rational drug development to treat dermatologic diseases. Thus, we performed multiplexed immunohistochemistry for CD4 and FOXP3 (the lineage-defining transcription factor of Tregs) on healthy skin sections obtained from eight different cutaneous sites, and quantified Tregs and Tcon in distinct regions. We found that Tregs (CD4+ FOXP3+) comprised roughly 20% of CD4+ T cells in skin and that Tregs and T-conventional cells (Tcon; CD4+ Foxp3) are enriched in follicularly dense skin and show preferential accumulation in perivascular and perifollicular niches in the upper dermis. Additionally, male skin shows a significant increase in the numbers of Tregs and Tcon, while female skin shows a higher Tcon:Treg ratio. We also find that the frequency of skin Tregs declines over time. Overall, we conclude that the upper dermal perivascular region is a niche that supports the accumulation of CD4+ T cells in steady-state human skin.

调节性T细胞(Tregs)是一种特殊的T淋巴细胞,处于免疫调节和组织修复的联系中。虽然我们认识到健康人体皮肤中存在大量treg,但对其微观解剖空间定位知之甚少。了解treg占据的特殊利基可能有助于合理开发治疗皮肤病的药物。因此,我们对从8个不同皮肤部位获得的健康皮肤切片进行了CD4和FOXP3 (Tregs的谱系定义转录因子)的多重免疫组化,并量化了不同区域的Tregs和Tcon。我们发现Tregs (CD4+ FOXP3+)约占皮肤中CD4+ T细胞的20%,Tregs和T-常规细胞(Tcon;CD4+ Foxp3-)在毛囊密集的皮肤中富集,并优先积聚在真皮上部的血管周围和毛囊周围壁龛中。此外,男性皮肤中Treg和Tcon的数量显著增加,而女性皮肤中Tcon:Treg的比例更高。我们还发现,皮肤Tregs的频率随着时间的推移而下降。总之,我们得出结论,真皮上部血管周围区域是一个支持稳态人体皮肤中CD4+ T细胞积累的生态位。
{"title":"CD4+ T Cells Occupy Perivascular and Perifollicular Niches in Healthy Human Skin","authors":"Courtney E. Macon,&nbsp;Annie Yang,&nbsp;Dhara Patel,&nbsp;Jeffrey P. North,&nbsp;Michael D. Rosenblum,&nbsp;Jarish N. Cohen","doi":"10.1111/exd.70023","DOIUrl":"10.1111/exd.70023","url":null,"abstract":"<div>\u0000 \u0000 <p>Regulatory T cells (Tregs) are specialised T lymphocytes that sit at the nexus of immune regulation and tissue repair. While it is appreciated that a substantial number of Tregs are present in healthy human skin, less is known about their microanatomic spatial localisation. Knowledge about the specialised niches that Tregs occupy may aid in rational drug development to treat dermatologic diseases. Thus, we performed multiplexed immunohistochemistry for CD4 and FOXP3 (the lineage-defining transcription factor of Tregs) on healthy skin sections obtained from eight different cutaneous sites, and quantified Tregs and Tcon in distinct regions. We found that Tregs (CD4<sup>+</sup> FOXP3<sup>+</sup>) comprised roughly 20% of CD4<sup>+</sup> T cells in skin and that Tregs and T-conventional cells (Tcon; CD4<sup>+</sup> Foxp3<sup>−</sup>) are enriched in follicularly dense skin and show preferential accumulation in perivascular and perifollicular niches in the upper dermis. Additionally, male skin shows a significant increase in the numbers of Tregs and Tcon, while female skin shows a higher Tcon:Treg ratio. We also find that the frequency of skin Tregs declines over time. Overall, we conclude that the upper dermal perivascular region is a niche that supports the accumulation of CD4<sup>+</sup> T cells in steady-state human skin.</p>\u0000 </div>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"33 12","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Microbiome-Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions 基于微生物组的皮肤疾病治疗的进展:当前的见解和未来的方向。
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-06 DOI: 10.1111/exd.70019
Tushar Madaan, Kyla Doan, Alexandra Hartman, Dominick Gherardini, Alec Ventrola, Yuhang Zhang, Nalinikanth Kotagiri

The human skin hosts an estimated 1000 bacterial species that are essential for maintaining skin health. Extensive clinical and preclinical studies have established the significant role of the skin microbiome in dermatological disorders such as atopic dermatitis, psoriasis, diabetic foot ulcers, hidradenitis suppurativa and skin cancers. In these conditions, the skin microbiome is not only altered but, in some cases, implicated in disease pathophysiology. Microbiome-based therapies (MBTs) represent an emerging category of live biotherapeutic products with tremendous potential as a novel intervention platform for skin diseases. Beyond using established wild-type strains native to the skin, these therapies can be enhanced to express targeted therapeutic molecules, offering more tailored treatment approaches. This review explores the role of the skin microbiome in various common skin disorders, with a particular focus on the development and therapeutic potential of MBTs for treating these conditions.

人体皮肤上估计有1000种细菌,这些细菌对维持皮肤健康至关重要。广泛的临床和临床前研究已经确立了皮肤微生物组在皮肤疾病中的重要作用,如特应性皮炎、牛皮癣、糖尿病足溃疡、化脓性汗腺炎和皮肤癌。在这些情况下,皮肤微生物组不仅被改变,而且在某些情况下,与疾病病理生理有关。微生物组为基础的疗法(mbt)是一种新兴的活体生物治疗产品,作为一种新的皮肤疾病干预平台具有巨大的潜力。除了使用已建立的皮肤原生野生型菌株外,这些疗法还可以增强以表达靶向治疗分子,提供更量身定制的治疗方法。这篇综述探讨了皮肤微生物组在各种常见皮肤疾病中的作用,特别关注mbt治疗这些疾病的发展和治疗潜力。
{"title":"Advances in Microbiome-Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions","authors":"Tushar Madaan,&nbsp;Kyla Doan,&nbsp;Alexandra Hartman,&nbsp;Dominick Gherardini,&nbsp;Alec Ventrola,&nbsp;Yuhang Zhang,&nbsp;Nalinikanth Kotagiri","doi":"10.1111/exd.70019","DOIUrl":"10.1111/exd.70019","url":null,"abstract":"<p>The human skin hosts an estimated 1000 bacterial species that are essential for maintaining skin health. Extensive clinical and preclinical studies have established the significant role of the skin microbiome in dermatological disorders such as atopic dermatitis, psoriasis, diabetic foot ulcers, hidradenitis suppurativa and skin cancers. In these conditions, the skin microbiome is not only altered but, in some cases, implicated in disease pathophysiology. Microbiome-based therapies (MBTs) represent an emerging category of live biotherapeutic products with tremendous potential as a novel intervention platform for skin diseases. Beyond using established wild-type strains native to the skin, these therapies can be enhanced to express targeted therapeutic molecules, offering more tailored treatment approaches. This review explores the role of the skin microbiome in various common skin disorders, with a particular focus on the development and therapeutic potential of MBTs for treating these conditions.</p>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"33 12","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/exd.70019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142785084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bactogram: Spatial Analysis of Bacterial Colonisation in Epidermal Wounds 杆状图:表皮伤口细菌定植的空间分析
IF 3.5 3区 医学 Q1 DERMATOLOGY Pub Date : 2024-12-03 DOI: 10.1111/exd.70018
Karl Wallblom, Fredrik Forsberg, Sigrid Lundgren, Jane Fisher, José Cardoso, Ganna Petruk, Ann-Charlotte Strömdahl, Karim Saleh, Manoj Puthia, Artur Schmidtchen

Skin barrier damage and subsequent development of harmful microbiota contribute to conditions such as wound infections, atopic dermatitis and chronic wounds, which impact millions of people globally and pose a significant economic burden on healthcare systems. Established microbial sampling methods, such as swabs and tissue biopsies, provide limited information on the spatial distribution of bacteria. We here describe a new method that produces a visual map of the distribution of cultivable bacteria, denoted ‘Bactogram’, across the whole wound and surrounding skin, suitable for image-based quantification. As part of an exploratory endpoint in a clinical trial we applied the Bactogram method to 48 suction blister wounds in 24 healthy volunteers. Bacteria developed in all wounds, predominantly on the skin under the dressing and near wound edges. Two quantification methods, based on visual scoring and image analysis, demonstrated high inter-, and intra-rater agreement and were used to characterise bacterial re-colonisation during epidermal wound healing. We also demonstrated proof of concept that the method can be used with chromogenic agar to enable spatial identification of pathogenic bacterial species, such as Staphylococcus aureus. In conclusion, this study introduces a simple method for sampling bacteria over large areas and generating a bacterial map that can identify spatial variations in bacterial composition and abundance in skin and wound conditions.

Trial Registration: ClinicalTrials.gov identifier: NCT05378997

皮肤屏障损伤和随后产生的有害微生物群会导致伤口感染、特应性皮炎和慢性伤口等疾病,这些疾病影响到全球数百万人,并给卫生保健系统带来沉重的经济负担。现有的微生物取样方法,如棉签和组织活检,只能提供有限的细菌空间分布信息。我们在这里描述了一种新方法,该方法可以产生可培养细菌分布的视觉地图,称为“Bactogram”,在整个伤口和周围皮肤上,适用于基于图像的量化。作为临床试验探索性终点的一部分,我们将Bactogram方法应用于24名健康志愿者的48个抽吸水疱伤口。所有伤口都有细菌,主要在敷料下和伤口边缘附近的皮肤上。基于视觉评分和图像分析的两种量化方法显示出高度的相互和内部一致性,并用于表征表皮伤口愈合过程中的细菌再定植。我们还证明了概念证明,该方法可以与显色琼脂一起使用,以实现病原菌物种的空间鉴定,如金黄色葡萄球菌。总之,本研究介绍了一种简单的方法,可以对大面积的细菌进行采样,并生成细菌图,可以识别皮肤和伤口条件下细菌组成和丰度的空间变化。试验注册:ClinicalTrials.gov标识符:NCT05378997
{"title":"Bactogram: Spatial Analysis of Bacterial Colonisation in Epidermal Wounds","authors":"Karl Wallblom,&nbsp;Fredrik Forsberg,&nbsp;Sigrid Lundgren,&nbsp;Jane Fisher,&nbsp;José Cardoso,&nbsp;Ganna Petruk,&nbsp;Ann-Charlotte Strömdahl,&nbsp;Karim Saleh,&nbsp;Manoj Puthia,&nbsp;Artur Schmidtchen","doi":"10.1111/exd.70018","DOIUrl":"https://doi.org/10.1111/exd.70018","url":null,"abstract":"<p>Skin barrier damage and subsequent development of harmful microbiota contribute to conditions such as wound infections, atopic dermatitis and chronic wounds, which impact millions of people globally and pose a significant economic burden on healthcare systems. Established microbial sampling methods, such as swabs and tissue biopsies, provide limited information on the spatial distribution of bacteria. We here describe a new method that produces a visual map of the distribution of cultivable bacteria, denoted ‘Bactogram’, across the whole wound and surrounding skin, suitable for image-based quantification. As part of an exploratory endpoint in a clinical trial we applied the Bactogram method to 48 suction blister wounds in 24 healthy volunteers. Bacteria developed in all wounds, predominantly on the skin under the dressing and near wound edges. Two quantification methods, based on visual scoring and image analysis, demonstrated high inter-, and intra-rater agreement and were used to characterise bacterial re-colonisation during epidermal wound healing. We also demonstrated proof of concept that the method can be used with chromogenic agar to enable spatial identification of pathogenic bacterial species, such as <i>Staphylococcus aureus</i>. In conclusion, this study introduces a simple method for sampling bacteria over large areas and generating a bacterial map that can identify spatial variations in bacterial composition and abundance in skin and wound conditions.</p><p><b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT05378997</p>","PeriodicalId":12243,"journal":{"name":"Experimental Dermatology","volume":"33 12","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/exd.70018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142762234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1